Which drugs does patent 6,436,989 protect, and when does it expire?
Patent 6,436,989 protects LEXIVA and is included in two NDAs. There has been one Paragraph IV challenge on Lexiva.
Protection for LEXIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-one patent family members in forty-three countries.